Subscribe To
Is alphabet a buy?
Alphabet's revenue and earnings beat expectations, but cloud revenue was a disappointment. The business...
November 2, 2023, 9:20 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company develop...
November 2, 2023, 9:17 am
Paypal gets a lift. why the stock could be too cheap to fail.
An earnings beat and new management are putting turnarou...
November 2, 2023, 9:16 am
Gold price forecast – gold markets recover slightly on thursday
Gold markets rallied just a bit during the trading sessi...
November 2, 2023, 9:15 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLingAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a c...
November 2, 2023, 9:15 am
Ftse 100 rallies ahead of boe rate decision
U.K. stocks advanced on Thursday as investors reacted to a slightly dovish stance from the Federal Reserve and awaited cues from the Bank of England m...
November 2, 2023, 9:14 am
Stock market today: wall street rises after federal reserve holds steady on interest rates
Stocks are rising after the Federal Reserve opted against press...
November 2, 2023, 9:14 am
Gbp/jpy keeps the red around 183.00, defends 100-day sma support ahead of boe
GBP/JPY drifts lower for the second straight day, though the downside remains limited. Intervention fears boost the JPY and turn out to be a key facto...
November 2, 2023, 9:14 am
At&t, verizon, or t-mobile: which telecom stock should you buy after earnings?
The three wireless carriers are all growing free cash flow faster than expected. Verizon and AT&T have ...
November 2, 2023, 9:14 am
After a year colt seals the $1.8b purchase of lumen emea
Colt, a service provider for numerous retail brokers, financial firms, and crypto exchanges, announced today (Thursday) that it has acquired Lumen EME...
November 2, 2023, 9:14 am
Sidus space awarded multi-million-dollar contract for commercial lunar transportation
Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, with a $10 mil...
November 2, 2023, 9:13 am
Editas medicine to present clinical data from the ruby and edithal trials of edit-301 at the ash 2023 annual meeting and in a company-sponsored webinar
Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr. Rabi Hanna from Cleveland Clinic Children's to...
November 2, 2023, 9:12 am
Building a sustainable portfolio: 3 esg stocks to buy and hold
At first, the idea of environmental, social and governance or ESG stocks to buy and hold doesn't seem particularly lucrative. Generally, an understand...
November 2, 2023, 9:10 am
Nasdaq 100, dow jones, s&p 500 news: starbucks earnings could set early tone
As Nasdaq Composite investors eye corporate earnings, including...
November 2, 2023, 9:10 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
November 2, 2023, 9:10 am
Invest in the future: buy & hold visa, mcdonald's and microsoft forever
The uncertainty surrounding interest rates and the mixed earnin...
November 2, 2023, 9:09 am
Ford reports lower us vehicle sales in october
Ford reported a 5.3% drop in total U.S. vehicle sales in October after the United Workers Union (UAW) staged walkouts at some of the company's plants ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Ecb's knot: policy rates now are at a good 'cruising altitude'
Current level of rates can remain for some timeShould be a little patient and not raise rates too much to prevent chok...
November 2, 2023, 9:08 am